Market Value3,491,094,084
Total Holdings66
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NKTR / Nektar Therapeutics
PTGX / Protagonist Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
MGX / Metagenomi, Inc.
ALEC / Alector, Inc.
NMRA / Neumora Therapeutics, Inc.
AGEN / Agenus Inc.
PACB / Pacific Biosciences of California, Inc.
AMAM / Ambrx Biopharma Inc.
IVVD / Invivyd, Inc.
PLRX / Pliant Therapeutics, Inc.
ZURA / Zura Bio Limited
ANIP / ANI Pharmaceuticals, Inc.
PRTA / Prothena Corporation plc Call
RPTX / Repare Therapeutics Inc.
KYMR / Kymera Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
PRTA / Prothena Corporation plc Put
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
TERN / Terns Pharmaceuticals, Inc.
ALGS / Aligos Therapeutics, Inc.
RAPT / RAPT Therapeutics, Inc.
NUVL / Nuvalent, Inc.
PRME / Prime Medicine, Inc.
MRSN / Mersana Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ACLX / Arcellx, Inc.
JAZZ / Jazz Pharmaceuticals plc
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
AGIO / Agios Pharmaceuticals, Inc.
COGT / Cogent Biosciences, Inc.
ANAB / AnaptysBio, Inc.
AXSM / Axsome Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc. Put
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
SWTX / SpringWorks Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
DVAX / Dynavax Technologies Corporation
ALNY / Alnylam Pharmaceuticals, Inc.
CYBN / Cybin Inc.
FATE / Fate Therapeutics, Inc.
HLVX / HilleVax, Inc.
OLMA / Olema Pharmaceuticals, Inc.
IONS / Ionis Pharmaceuticals, Inc.
SYRE / Spyre Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
GHRS / GH Research PLC
ALLK / Allakos Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
CYTK / Cytokinetics, Incorporated
OCUL / Ocular Therapeutix, Inc.
INSM / Insmed Incorporated
EWTX / Edgewise Therapeutics, Inc.
ENGN / enGene Holdings Inc.
NRIX / Nurix Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
TRML / Tourmaline Bio, Inc.
APGE / Apogee Therapeutics, Inc.
PYXS / Pyxis Oncology, Inc.
DYN / Dyne Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
TVTX / Travere Therapeutics, Inc.
GH / Guardant Health, Inc.
ANRO / Alto Neuroscience, Inc.
ALKS / Alkermes plc
RGLS / Regulus Therapeutics Inc.
VIGL / Vigil Neuroscience, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
GERN / Geron Corporation
RLMD / Relmada Therapeutics, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
NTLA / Intellia Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
MNMD / Mind Medicine (MindMed) Inc.
AMGN / Amgen Inc.
CYTK / Cytokinetics, Incorporated Call
EDIT / Editas Medicine, Inc.